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Alcohol abuse is a problem in our society. There are few treatments available, in 
part due to the unclear molecular mechanisms of ethanol’s effects. Human studies 
indicate that there is a genetic component influencing disease susceptibility, and that an 
individual’s initial response to alcohol can predict their development of addiction. We 
have taken a forward genetics approach to study one component of initial response, 
acute functional tolerance (AFT), in Caenorhabditis elegans. We identified bet11, a 
mutation that causes animals to be defective in the development of AFT. Genetic 
analysis suggested that the gene that bet11 disrupts participates in a synthetic genetic 
interaction with an unlinked natural allelic variant in another gene that alters ethanol 
  2 
response. We also examined the role of lipid membrane composition in the response to 
ethanol. Identification of modulators that are responsible for alcohol-induced responses 
will provide a greater understanding of the mechanisms that cause alcohol-related 
diseases. 
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Chapter 1: Introduction 
 
Alcohol 
Alcohol is a widely used and accepted drug in our society. Even with the 
associated negative consequences of decreased mental health, increased social 
problems, and increased risk of other diseases and disorders, the use of alcohol has 
lead to high incidences of abuse, dependence, and addiction. Alcohol abuse occurs 
when alcohol consumption leads to problems such as physical injury and failure to 
attend to important responsibilities at home, work, or school, but not physical addiction, 
which produces symptoms such as anxiety, nausea, and sweating (O'Connor 2007). 
Alcohol addiction is a compulsive disorder where continued use and abuse of the drug 
persists despite its negative consequences. Human alcohol dependence is a chronic 
relapsing disorder with characteristics of tolerance, drug withdrawal, excess 
consumption, and impaired social and work activities (DSM-IV 1994). Studies have 
shown that alcoholics have a higher risk for psychiatric disorders, which is likely to be 
due to intoxication and withdrawal (Robins, Helzer et al. 1984; Kessler, Crum et al. 
1997; Schuckit, Tipp et al. 1997; Raimo and Schuckit 1998). A variety of independent 
outcomes can be linked to repeated heavy alcohol drinking. These include, but are not 
limited to changes in mood, anxiety, schizophrenia, bipolar manic-depressive disease, 
attention deficit hyperactivity disorder (ADHD), and other substance use  
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(Tsuang and Lohr 1994; Winokur, Coryell et al. 1996; Disney, Elkins et al. 1999). 
Alcohol abuse and the comorbidities associated with alcoholism have not only produced 
physical detrimental effects, but have also caused high economical expenditures. The 
overall effects of alcohol abuse and dependence are a serious societal problem. 
Alcohol interactions 
Alcohol abuse and dependence may involve many neural mechanisms. These 
mechanisms play a role in a person’s initial sensitivity, development of tolerance, and 
continued desire or craving for the drug. The contribution and influences of these neural 
mechanisms to an individual’s drinking behavior remains unclear. Currently, it is thought 
that alcohol can act directly and indirectly on ethanol targets to produce a response and 
has been commonly accepted to have a neurochemical effect (Lovinger and Crabbe 
2005; Vengeliene, Bilbao et al. 2008). Due to ethanol’s effects on a broad range of 
targets identified with in vitro studies, our understanding of how these molecular 
mechanisms are involved in the in vivo responses to ethanol are limited and have made 
development of new treatments less successful. These limitations are chiefly due to the 
simple molecular structure of ethanol. Ethanol has only two reactive sites present: a 
hydroxyl (-OH) group and a short carbon backbone (Lovinger and Crabbe 2005). In 
addition, the molecule does not form ionic or covalent bonds, which causes it to have 
poor reactivity. This poor reactivity leads to low potency of the drug allowing for a large 
range of ethanol effects from intoxication to anesthesia. Ethanol is also widely 
distributed to many cellular compartments and has weak interactions with many 
potential target molecules making it harder to pinpoint and specifically target and 
measure its affinity. 
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Ethanol has a promiscuous nature and studies have elucidated a myriad of 
neuronal substrates, proteins, and processes that are affected by the drug. Other drugs 
of abuse share some of the same targets and interactions. Ethanol is predicted to have 
an effect on neuronal plasticity and regulation. It has been shown to influence a wide 
range of areas including the brain glutamatergic system, CREB proteins, stimulation of 
VTA dopaminergic neurons, and involvement of mesocorticolimbic and amygdala 
circuitry (Lovinger and Crabbe 2005). Other potential proteins, genes, and enzymes that 
might also influence an alcoholic’s vulnerability include adenylyl cyclase, G-proteins, 
protein kinase C, the neuropeptide Y pathway, the serotonin system, dopamine, GABA, 
noreprinephrine, monoamine oxidase, and the alcohol metabolizing enzymes, alcohol 
dehydrogenase and aldehyde dehydrogenase. Furthermore, many of these regulators 
interact with one another and when one is disrupted, other substrates are effected as 
well and it could lead to detrimental changes (Schuckit 2002). 
Available treatments for alcohol dependence 
Current treatments for alcohol abuse and dependence include drugs that hinder 
alcohol consumption and support programs that guide alcoholics to wean alcohol from 
their lives. Currently there are three FDA approved drugs to treat alcohol dependence: 
Disulfiram (Antabuse), Naltrexone (ReVia), and Acamprosate (Campral). Disulfiram 
targets the ethanol metabolic pathway. After alcohol consumption, ethanol is 
metabolized by alcohol dehydrogenase into acetaldehyde. Acetaldehyde is further 
broken down into acetic acid by aldehyde dehydrogenase, which is excreted by the 
body. Disulfiram blocks the enzyme acetaldehyde dehydrogenase. This inhibition 
results in an increase in acetaldehyde when alcohol is consumed. Acetaldehyde is 
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extremely toxic and causes symptoms similar to a hangover such as nausea, vomiting, 
headache, and an increase in heart rate. These aversive effects discourage the 
consumption of alcohol. Another drug to treat alcohol dependence is naltrexone. While 
the mechanism of action of naltrexone is not fully known, it acts as a competitive 
antagonist at the µ- and κ-opioid receptors and minimally at the δ-opioid receptors 
(Shader 2003). It is proposed that an opioid receptor antagonist works within the 
dopaminergic mesolimbic pathway, which is linked to the rewarding effects of drugs. 
Naltrexone is prescribed to reduce alcohol craving, but will not relieve or stop 
withdrawal symptoms. Long-term use of alcohol causes an increase in the number of 
NMDA receptors. When a person is withdrawn from alcohol, there is a surge of 
excitatory neurotransmitters that activate these receptors at a higher than normal level 
(Tsai, Ragan et al. 1998). Acamprosate acts by targeting NMDA receptors and blocking 
the release of excitatory neurotransmitters that are produced after withdrawal from 
alcohol (De Witte, Littleton et al. 2005). 
These drugs alone and in combination have been studied extensively to analyze 
their effectiveness. Disulfiram and naltrexone are FDA approved drugs, and are shown 
to be effective independently, but have room for improvement. These drugs in 
combination did not show any further advantage or improvement in treating alcohol 
dependence (Petrakis, Ralevski et al. 2007). Acamprosate, the newest and most 
promising of the drugs, is effective in reducing cravings and produces conditioned 
negative reinforcement and withdrawal (Littleton 1995; Kiefer and Mann 2010). 
Acamprosate has been shown to have fewer side effects and in combination with either 
naltrexone or dilsulfiram may be more effective than with treatment of acamprosate 
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alone (Hunter and Ochoa 2006). Due to the low success rate of current drug treatments, 
there are still areas that can be better understood to improve drug development. 
More traditional methods of treatment based on behavioral therapies include 
Alcoholics Anonymous, the 12-Step program, and residential group therapies. These 
treatments show potential, but lack long-term effectiveness and have a high rate of 
relapse. Hospital or residential-based programs are more effective than outpatient 
programs in treating alcoholism (O'Malley, Jaffe et al. 1996; Fuller and Hiller-Sturmhofel 
1999). However, due to health care costs outpatient programs are more desirable. 
Furthermore, it has been proposed that combination of psychotherapy and 
pharmacotherapy may be a promising supplemental approach. 
Genetic factors influence susceptibility to alcoholism 
There are two major factors that influence an individual’s susceptibility to 
becoming an alcoholic, genetics and environment. First, it has been shown that genetic 
factors contribute to 40-60% of one’s susceptibility to alcohol abuse and alcoholism 
(Kendler, Prescott et al. 1997; Schuckit 2002). The remainder of an individual’s risk is 
attributed to non-genetic factors. Initial sensitivity differs among individuals and has 
been linked to the susceptibility to alcoholism later in life (Schuckit, Smith et al. 2004; 
Lovinger and Crabbe 2005). One study examined sons of alcoholics, between the ages 
of 18 and 20 years old, and evaluated their initial level of response to alcohol and then 
followed up 8.2 years later to assess their alcohol use and compared any known 
psychological disorders within their family. This study showed that family history plays a 
role in developing alcoholism, but prior psychological disorders were unrelated to 
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alcohol abuse and dependence (Schuckit and Smith 1996). Another study looked at 
subjects that were related to alcoholics and evaluated their level of response to alcohol 
challenges. Patients were tested and evaluated 15 years later for alcoholism using a 12-
question Self-Rating of the Effects (SRE) of alcohol. From this study, it was shown that 
young adults that had a relatively low level of response to alcohol, when tested later in 
life, had a higher incidence of alcoholism (Schuckit, Smith et al. 1997). These studies 
confirm that an individual’s genetic background plays a significant role in the 
predisposition to the future development of alcoholism.  
The second non-genetic factor that plays a role in susceptibility to alcoholism is a 
person’s environmental experiences (Kendler, Prescott et al. 1997; Schuckit 2002). 
Studies analyzing different populations have shown that there is a correlation between 
diagnosed alcohol abusers and their environmental influence. While there have been 
implications that environment plays a role in the development of alcoholism, population-
based studies of twins have shown that it has only a minimal effect (Prescott and 
Kendler 1999). Twin studies from the Vietnam Era Twin Registry analyzed 
environmental factors that contributed to the decision to seek treatment and found there 
was a 40% variance between the shared environment and the influence to seek 
treatment (True, Heath et al. 1996). The decision to seek treatment is an inadequate 
measure for alcoholism, but is influenced by both genetic and environmental factors and 
may play a role in the continuation and degree of drinking. Understanding that 
environmental and more importantly that genetic factors play a large role in the 
development of alcoholism, it provides a gateway into identifying other mediators and 
the mechanisms of action that are involved in development alcoholism.  
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Acute functional tolerance  
A significant problem in many drugs of abuse is the development of tolerance, 
which leads to an increase in drug dose or use within an individual. In contrast, drug 
resistance is the requirement of a larger dose of a drug in order to experience the same 
effect compared to another subject. Tolerance can be due to both the break down or 
metabolic (pharmacokinetic) response to ethanol, as well as metabolism-independent 
changes. Tolerance is commonly a lower responsiveness to a drug in the nervous 
system and is known as pharmacodynamic tolerance or functional tolerance (Atkinson 
2009). The pharmacodynamic effects of tolerance to ethanol can be found in three 
different forms: acute, rapid, and chronic (Mellanby 1919; Tabakoff, Cornell et al. 1986; 
Khanna, Morato et al. 2002). Acute functional tolerance (AFT) to ethanol is described as 
a pharmacodynamic adaptation within a short, single exposure to ethanol that 
counteracts the cellular disturbances. The degree of AFT is assumed to develop in a 
linear fashion over time and the slope of the line is a measure of the magnitude of AFT 
effect. Rapid tolerance is the diminished response to alcohol upon administration of a 
second dose within 24 hours after the first administration. Chronic tolerance is defined 
as the reduction in sensitivity to a drug that results from repeated administration of the 
drug over a period of time. Largely, the main difference between the different types of 
tolerance described here is that acute tolerance is the reduction in sensitivity to a drug 
that results from a single administration or within the duration of one continuous dose of 
a drug rather than following repeated doses (Kalant, LeBlanc et al. 1971).  
The development of AFT has been linked to the predisposition of alcohol-related 
diseases later in life, which makes it a strong candidate to study. The development of 
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AFT is thought to play a role in neuronal plasticity and advance the development of 
alcohol dependence. Frequently AFT is measured in combination with initial sensitivity, 
the first detectable response to ethanol. In studying behavior and other neuronal 
processes, it is difficult to accurately measure a subject’s true initial sensitivity. Since 
the response is measured immediately after drug administration, experimental error 
limits the accuracy of the results due to the fact that it is predicted that neurons start 
adapting almost immediately after ethanol exposure. Thus initial sensitivity and AFT are 
combined to give a more accurate measure of sensitivity and response to ethanol. 
Through these measures, it is thought that functional tolerance to alcohol is due to a 
neuronal resistance response and is involved in plasticity changes that are similar to 
those involved in learning and memory (Tabakoff, Cornell et al. 1986; Berger, Kong et 
al. 2008).  
Neuropeptide Y (NPY) receptors have been shown in different studies to 
influence AFT. NPY receptors are a class of G-protein coupled receptors and NPY is 
the most abundant neuropeptide in the brain (Erickson, Clegg et al. 1996). In C. 
elegans, neuropeptide Y-like receptor 1 (NPR-1), which is homologous to the human 
NPY receptor was found to be a negative regulator of AFT. Natural variation in npr-1 
activity in C. elegans causes variation in ethanol response between wild strains. It has 
been shown that NPR-1 regulates AFT and has been predicted that increased function 
of this protein will decrease the rate of recovery from ethanol (Davies, Bettinger et al. 
2004). Furthermore, Davies et al. has demonstrated that extended exposure to ethanol 
caused animals to down-regulate their NPR-1 activity. Other supporting genetic and 
pharmacological studies done on flies and mammals have shown that NPF and NPY 
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respectively, also regulate the response to ethanol. In mammals, NPY has also been 
shown to suppress anxiety and the responsiveness to stress and aversive stimuli, which 
may be common reasons why individuals are drawn to drinking (Palmiter, Erickson et al. 
1998; Bannon, Seda et al. 2000; Heilig and Thorsell 2002). NPY, while a strong 
candidate in mediating ethanol tolerance, is not believed to be the sole contributor. 
Since ethanol is a very simple, widely distributed drug that has been shown to hit 
multiple targets, it is proposed that there are many mediators and interactions with 
targets that lead to ethanol sensitivity and tolerance.  
 
SLO-1, an ethanol regulator 
SLO-1, an important regulator of neurotransmitter release, controls the synaptic 
strength and plasticity for higher brain function. A variety of potassium channels are 
located in the presynaptic nerve terminal along with SLO-1 channels. SLO-1 channels 
are activated by both calcium and membrane depolarization. Calcium activated BK 
channels were first discovered in Drosophila through slowpoke. Slowpoke, is 
homologous to slo-1 in C. elegans and interestingly, slo-1 was selectively isolated in a 
forward genetic screen as the only ion channel mutant that plays a role in 
neurotransmitter release (Wang, Saifee et al. 2001). This suggested that slo-1 is an 
important and unique regulator of neurotransmitter release. The identification of the 
action of ethanol on SLO-1 channels has provided a gateway and tool to further studies 
on the role of ethanol. Importantly, SLO-1 has high homology between C. elegans, 
Drosophila, rodents, and humans where the structural components are similar. SLO-1 in 
C. elegans is expressed in neurons and body-wall muscle. SLO-1 is critical for muscle 
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function and mutant slo-1 worms have muscle degeneration similar to those seen in 
dystrophin mutants (Carre-Pierrat, Grisoni et al. 2006).  
slo-1, in C. elegans is a voltage-gated potassium channel, which is activated by 
ethanol . In ethanol target screens, which are used to identify mechanisms that are 
responsible for ethanol intoxication, numerous loss-of-function slo-1 alleles were 
isolated (Davies, Pierce-Shimomura et al. 2003). It was shown that slo-1 loss-of-
function mutants have a strong resistance to ethanol in speed and egg-laying behavior. 
In contrast, C. elegans with hyperactivated SLO-1 channel showed behaviors similar to 
ethanol intoxication in the absence of ethanol. Additionally, it has been found that over 
expression of slo-1 also restored ethanol intoxication to slo-1 mutant animals. Through 
electrophysiological experiments, it has been shown that pharmacologically relevant 
concentration of ethanol activates the SLO-1 channel. Studies on mammalian BK 
channels have also suggested that ethanol directly affects these channels at relevant 
concentrations (Dopico, Lemos et al. 1996; Dopico, Anantharam et al. 1998).  
 
Membrane lipids influence ethanol sensitivity and tolerance 
Most studies on ethanol sensitivity and tolerance focus on protein targets, 
however recent studies have shown that membrane lipids may play a larger role. BK 
and other voltage-gated potassium channels are sequestered mostly in lipid 
microdomains of lipid membranes and cholesterol content modulates the role of ethanol 
activation of BK channels (Marty 1981; Dopico, Lemos et al. 1996; Crowley, Treistman 
et al. 2003; Yuan, O'Connell et al. 2008). Acute ethanol tolerance has been observed in 
stable (20:1) phosphatidylcholine-dioleoylphosphatidylethanolamine (PC-DOPE) and 
the activity of the BK channel is influenced by the ratio of cholesterol to phospholipids in 
  13 
the membrane in which the channel is located. Changes in the lipid bilayer composition 
may also cause changes in ethanol sensitivity by influencing the BK channels (Yuan, 
O'Connell et al. 2008). Ethanol modifies the gating and conductance properties of the 
BK channel and increases channel activity (Dopico, Lemos et al. 1996). When ethanol 
is presented into the system for a period of time and leads to the development of 
tolerance, there is a decrease in ethanol activation on the channel and a decrease of 
BK current density due to the possible increase in cholesterol that plays a role in the 
overall lipid composition and sequestering of BK channels (Pietrzykowski, Martin et al. 
2004).   
Triacylglycerides (TAG), a type of lipid is modulated by lipases. The lipase, LIPS-
7 negatively regulates the level of TAGs in C. elegans and ultimately may alter the 
ethanol response through CTBP-1 (Figure 1). CTBP-1 is a NAD(H)-dependent 
transcriptional co-repressor that is homologous to humans and has been linked to 
increased lifespan in C. elegans (Chen, Whetstine et al. 2009).  When CTBP-1 is 
inhibited, lips-7 is over expressed, which leads to a decrease of TAG. On 400mM 
ethanol, lips-7(ok3110) develops AFT faster and has higher resistance to ethanol than 
N2, while ctbp-1(eg613) is more sensitive to ethanol and has a slower development of 
AFT (Bettinger, Leung et al. 2011, unpublished). By altering levels of lips-7, ctbp-1 
inversely influences the lipid composition and the levels of TAG, and thus producing 
opposing effects to ethanol sensitivity and AFT. Mammalian BK channels have been 
found within lipid microdomains and their activation and potentiation may be modified in 
response to changes in the lipid membrane composition (Bravo-Zehnder, Orio et al. 
2000; Treistman and Martin 2009). Together these findings suggested that TAGs might 
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play a role in the sensitivity and development of tolerance in response to ethanol. 
 
Using model organisms to study alcoholism 
Different model organisms have been used to research alcohol use, abuse, 
dependence, and comorbidities with alcoholism.  Animal models allow researchers to 
conduct experiments that cannot be done on human subjects. Manipulation of genetic 
background, environment, route of administration, and diet are some advantages when 
studying ethanol. Also, the ability to test and analyze cells and tissues provides another 
asset in studying alcohol-related diseases. Due to the high homology between humans, 
rodents, and C. elegans, the ability to use different model organisms provides a 
powerful tool in identifying and understanding the role of alcohol in humans. 
 
Ethanol studies in rodents 
In rodents, the loss of righting reflex (LORR) and the blood (brain) ethanol 
concentration (BEC) are measured in tandem in order to analyze the acute effects of 
alcohol. The LORR assesses the level of sensitivity to the effects or sedation to alcohol. 
It is measured behaviorally by the ability of the animal to right itself after being turned on 
its back. AFT can be estimated by taking the BEC levels at two time points during 
ethanol impairment at the rising and falling arms of the BEC curve (Ponomarev and 
Crabbe 2004). This will allow comparison of the BEC for initial sensitivity to its recovery. 
AFT can be influenced by many factors including the genetic background of a subject 
and the experimental treatment. AFT can only be estimated due to the constraints of the 
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ability to accurately measure the true initial ethanol response once alcohol has been 
administered.  
Alcohol tolerance has been seen in many observable effects of ethanol including 
motor impairment, sedation, and hypothermia. Studies on adolescent and adult rats 
have shown that alterations in the NMDA receptor system may decrease ethanol 
sensitivity in response to the enhancement of acute tolerance (Ramirez, Varlinskaya et 
al. 2011). Ethanol sensitivity has also shown to be regulated by Fyn, a non-receptor 
type tyrosine kinase. Animals lacking Fyn were hypersensitive to the effects of ethanol 
and found that there was no tyrosine phosphorylation in the NMDA receptor in the 
hippocampus as seen in control mice (Miyakawa, Yagi et al. 1997). Another study 
showed that a decrease of protein kinase C epsilon (PKCε) contributes to AFT. 
Knockout mice with a loss of PKCε showed signs of increased ethanol intoxication and 
reduced ethanol self-administration. In wild-type mice in vivo ethanol exposure 
produced AFT and yielded an increase in phosphorylation of PKCε (Wallace, Newton et 
al. 2007).  
As mentioned previously, NPY receptors are an ethanol regulator among a 
number of homologous species. NPY deficient mice show an increase in tolerance to 
ethanol and an increase in alcohol consumption of different concentrations of ethanol 
(Thiele, Marsh et al. 1998; Thiele, Koh et al. 2002). NPY knockout mice were also less 
sensitive to the sedative and hypnotic effects of ethanol. Similarly, the plasma ethanol 
concentrations were unchanged compared to wild type controls. NPY receptor subtypes 
Y1 and Y5 in mice have been shown to regulate food intake and alteration in food 
consumption, anxiety, and ethanol consumption. An increase in subtype Y1 resulted in 
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a decrease in ethanol consumption, where knockout Y1 mice also showed a decreased 
sensitivity.  
A method of bidirectional breeding allows for a more direct approach of analyzing 
ethanol sensitivity. Variations in genes that promote AFT and reduce the behavioral 
uncoordinated effects of ethanol can be identified using and comparing mice that have a 
high acute functional tolerance (HAFT) and mice that have a low acute functional 
tolerance (LAFT). The concept is that HAFT mice will have more genetic variants that 
contribute to AFT compared to LAFT mice and important mediators can be identified 
(Tabakoff, Bhave et al. 2003). This study identified candidate genes for the complex 
phenotype of ethanol tolerance. Specifically they indicated the importance of a signal 
transduction cascade that involved the glutamate receptor δ2 protein, the Ephrin B3 
ligand, and the NMDA receptor. These studies confirm that there are multiple variations 
that may alone or in combination mediate the development of tolerance and addiction to 
the incoordinating effects of alcohol.  
Ethanol studies in Caenorhabditis elegans 
Natural wild strains, N2 and CB4856 have been shown to have different rates of 
development of AFT when analyzed for ethanol sensitivity and tolerance. N2 has a 
slower development of AFT, where CB4856 has a faster development of AFT. N2 and 
CB4856 are wild isolates that were found in two separate locations and evolved many 
millions of years apart. This promotes a low level of molecular diversity between the two 
strains and results in many single nucleotide polymorphisms (SNP) on average, one 
every 800 base pairs across the genome. The major genetic difference between the two 
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wild strains that confers ethanol sensitivity and tolerance was mapped to a single gene, 
npr-1 (Davies, Bettinger et al. 2004). Mutations in npr-1 cause behavioral changes in 
response to ethanol and it has been shown that a decrease in NPR-1 signaling occurs 
during extended ethanol exposure (~20 hours). By analyzing multiple alleles of npr-1, 
npr-1 complete loss-of-function mutants developed tolerance more rapidly than weaker 
alleles. Unchanged internal ethanol concentrations confirmed that a decrease in npr-1 
modulates the increase in ethanol tolerance through a mechanism that does not involve 
ethanol metabolism. Varying the levels of the gene npr-1 modifies the rate of 
development of acute functional tolerance to ethanol.  
Two alleles of NPR-1 have been identified and are present in many wild isolates. 
A variation at position 215 in NPR-1 caused changes in social and ethanol behavior. N2 
contains the NPR-1 isoform 215V, a solitary feeding strain, while CB4856 has the lower 
functioning npr-1 allele isoform, 215F (de Bono and Bargmann 1998). NPR-1 
expression was located by using a green fluorescent protein and was expressed in 
sensory neurons, interneurons, motor neurons, and pharyngeal neurons. Further 
analysis of neurons AUA, AQR, PQR, and URX, where their activity was suppressed 
through the activation of a K+ channel, depicted a decrease in social feeding (Coates 
and de Bono 2002). These neurons are predicted to play a role in the integration of 
antagonistic signals that control the choice between social and solitary behavior and 
ultimately suggesting the importance of these neurons for this behavior. The two npr-1 
alleles, 215V or 215F can be found in many wild strains, but no other isolate has been 
identified (de Bono and Bargmann 1998).  
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In C. elegans, studies have shown that ethanol tolerance and food-dependent 
behaviors can be separable (Davies, Bettinger et al. 2004). CB4856, npr-1(215F), 
showed an increased speed on food and an increase in bordering, a preference for 
thicker parts of the lawn and a low O2 environment (hyperoxia avoidance) (Chang, 
Chronis et al. 2006). The ocr-2(ak47) mutation suppressed the clumping and faster 
speeds on food phenotype of a loss-of-function npr-1 mutation (de Bono, Tobin et al. 
2002). When tested in a npr-1(lf) background, the ocr-2(ak47) mutation was not able to 
significantly suppress the npr-1(lf) rapid development of AFT phenotype (Davies, 
Bettinger et al. 2004). In addition, the expression of npr-1(+) in the npr-1 expressing 
neurons (AQR, PQR, and URX), that is sufficient to rescue the social behavior 
phenotype of npr-1(lf), was unable to rescue the acute locomotor sensitivity phenotypes 
of npr-1. This suggests that there is a distinct difference between the locomotor speed 
phenotype and the clumping and bordering phenotype. NPR-1 is a regulator of the 
neuroadaptive process in response to ethanol and other social behaviors. Natural 
variation between wild-type strains N2 and CB4856 portrayed differences in the 
development of AFT and has been mapped to a single gene, npr-1.  
Caenorhabditis elegans as a model organism 
Caenorhabditis elegans (C. elegans) are an excellent model to study the 
molecular basis of alcohol tolerance, abuse, and alcoholism. In their natural habitat, 
they are found in the soil of temperate regions or within rotten fruit and feed on bacteria. 
Within a laboratory, they are easily and inexpensively cultured and maintained on agar 
plates and feed off on Escherichia coli. Their development and biological aspects are 
very well characterized and understood. They have a short reproductive cycle, where 
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they are able to grow from egg to egg-laying adult in 3 days. With a short generation 
time, a self-fertile hermaphrodite can also produce a brood size of approximately 300 
allowing for a large-scale production of animals in a short period of time. Furthermore, 
C. elegans are transparent, which provides a good canvas for detection of in vivo 
fluorescence markers; this aids in the visualization of neurons, processes such as 
axonal growth, embryogenesis, and fat metabolism. While C. elegans are multicellular 
organisms, hermaphrodites contain only 959 somatic cells and 302 neurons. Also, their 
entire genome has been fully sequenced, with approximately 20,470 protein-coding 
genes. Importantly, it has been shown that 40% of the C. elegans genome is 
homologous to humans making them a very attractive model organism to use (Hodgkin 
1998). All of these features make C. elegans a good tool for genetic manipulation and 
can be used for early research in understanding the molecular mechanism of many 
human diseases including alcoholism. 
 
 
 
 
 
 
 
 
 
 
 
 
  20 
 
 
 
                   
 
 
 
 
 
lips%7'
Triacylglycerides,
Increase,ac.va.on,of,slo%1'channel,
Ethanol,Sensi.ve,
ctbp%1'
EtOH,
SLO;1,
ac.vated,
by,EtOH,
SLO;1,
K+,
K+,
K+,
K+,
Decreased,TAG,levels,
lips%7'
Triacylglycerides,
Decrease,ac.va.on,of,slo%1'channel,
Ethanol,Resistance,
ctbp%1'
EtOH,
SLO;1,
ac.vated,
by,EtOH,
SLO;1,
Increased,TAG,levels,
K+,
K+,
Jill,BeEnger,
  21 
Figure 1. Mediating effects of triacylglyceride levels on ethanol sensitivity  
lips-7, a lipase that regulates the triacylglyceride levels in the lipid bilayer is inversely 
modulated by ctbp-1. It is proposed when triacylglyceride levels are low, ethanol is able 
to activate more SLO-1 channels, which mediates the effects of sensitivity to ethanol. In 
contrast, when triacylglyceride levels are high, more SLO-1 channels are immersed 
within lipid bilayers and fewer channels are activated, thus producing a resistant 
response to ethanol.  
 
 
 
 
 
 
 
 
 
 
 
 
  22 
Chapter 2: bet11 regulates the development of acute functional tolerance 
 
Specific Aim 1: Identification of the gene that is disrupted by the bet11 mutation; 
this gene is a regulator of acute functional tolerance.  
Rationale: The nematode neuropeptide receptor (NPR-1) antagonizes the 
development of acute functional tolerance (AFT) by ethanol, however evidence 
suggests it is not the sole regulator of tolerance. While there has been an abundance of 
research investigating the behavioral effects of ethanol, the various molecular 
mechanisms underlying these effects are still not very well understood. Utilizing a 
forward genetics approach, we probed the entire C. elegans genome to screen for 
genes involved in the development of AFT, by investigating animals that were unable to 
develop AFT. Specifically, we identified mutations that caused animals to become slow 
developers of AFT in a genetic background that was a fast developer of AFT.  
Materials and Methods: 
Nematode maintenance and strains  
Nematodes were maintained on nematode growth medium (NGM) agar plates 
seeded with OP50, E. coli food, and kept at 20°C. The strains that were used in this 
study were: N2, CB4856, npr-1(ky13), bet8;npr-1(ky13), bet11;npr-1(ky13), bet14;npr-
1(ky13), eg626;npr-1(ky13), F23C8.6(ok3325), F23C8.7(tm3394). Strains were 
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provided by R. Barstead (Gene Knockout Consortium), J. Bettinger (Virginia 
Commonwealth University, Richmond, VA), S. Mitani (National Bioresource Program 
and Tokyo Women’s Medical College, Tokyo, Japan), and the C. elegans Genetics 
Center (University of Minnesota, Minneapolis, MN).  
Mutagenesis  
Mutagenesis was performed on npr-1(ky13) animals. The npr-1(ky13) strain 
contains a null mutation at npr-1 and causes a fast development of AFT phenotype. In 
order to locate genes that disrupt AFT, we utilized and mutated npr-1(lf) animals, that 
are fast developers of AFT, and screen for slow developers of AFT or animals that have 
an interrupted development of tolerance. In order to robustly visualize the development 
of AFT, npr-1(ky13) were used as a sensitized background. The npr-1(ky13) mutation 
was used to sensitize the strain to be mutagenized, so that the slow developers of AFT 
could be identified in the progeny and differentiated from the parental npr-1(ky13) fast 
developers of AFT. npr-1(ky13) animals underwent ethyl methanesulfonate (EMS) 
mutagenesis, which generally induces single base pair mutations or small 
deletions/insertions to produce varied mutant phenotypes; slow developers of AFT 
animals were specifically selected from the progeny of the mutagenized animals as 
follows. npr-1(ky13) worms were grown normally on seeded OP50 (NGM) agar plates at 
20°C until most animals grew to the L4 stage and then were washed off the plate with 
M9 (42.3 mM Na2HPO4, 22.0 mM KH2PO4, 85.6 mM NaCl, 0.1 mM MgSO4) into a 
plastic 15 mL conical tube. Worms were spun down at maximum speed in a clinical 
centrifuge for 30 seconds and the supernatant was discarded. The worm pellet was 
washed with M9, inverted several times, and re-spun. The supernatant was discarded 
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and the pellet was then resuspended in 2 mL of M9. The 2 mL of worms were treated 
with 50 mM liquid EMS. The conical tube was placed on a rocker for 4 hours at 20°C. 
After mutagenesis, worms were washed twice with M9 and then transferred to NGM 
plates with OP50 for 15 minutes – 2hrs, at which point healthy looking worms were 
picked and bred for two generations. The F2 progeny was used to ensure that any 
induced mutations would be homozygous in a quarter of the animals tested and the 
animals were screened for ethanol tolerance (see below).  
Ethanol administration 
Ethanol was administered to the worms through NGM agar plates. Plates were 
dried at 37°C with lids off and then cold 100% ethanol (200 proof) was added to the 
appropriate final concentration (weight to volume). Plates were sealed with parafilm and 
allowed to equilibrate for 2 hours prior to transferring the worms onto the plate. Worms 
were exposed to ethanol by crawling on top of the agar and through a thin layer of the 
liquid extruded from the plate 
Ethanol chemotaxis assay 
Mutagenized animals were subjected to a chemotaxis assay on ethanol in order 
to separate and isolate animals that displayed a change in the development of AFT. The 
F2 progeny of mutagenized npr-1(ky13) animals were incubated in 300 mM ethanol 
(ethanol:M9 solution) for 90 minutes to develop tolerance before being placed at one 
spot (origin) of a 300 mM ethanol NGM plate. On the opposite side of the plate was a 
spot of attractant (butanone:EtOH (1:1000) and NaAzide). Worms were allowed to move 
freely for 90 minutes; animals are attracted to butanone and in these conditions, npr-
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1(ky13) animals have developed sufficient tolerance to be able to chemotax to the 
attractant within 90 minutes. After 90 minutes, animals that were not able to chemotax 
to the attractant spot effectively were animals that we believed were hypersensitive to 
the effects of ethanol and unable to develop tolerance. These affected animals were 
individually picked, allowed to produce self-progeny, and the progeny was tested for 
ethanol sensitivity and the development of tolerance through at least two more trials of 
ethanol sensitivity experiments to verify the altered response to the effects of ethanol. 
Strains with a confirmed altered ethanol response phenotype were maintained and the 
position of the induced mutation was identified using genetic mapping (see below). 
False positive ethanol sensitive results could be due to environmental factors or injury to 
the animal through handling; such animals were discarded following subsequent testing. 
Ethanol sensitivity and acute functional tolerance assay 
Animals were tested for their ethanol response phenotype visually as follows: 
Animals were age-matched in the L4 stage, and allowed to mature overnight into adults. 
Assay plates were dried by incubation at 37°C with lids off for 90 minutes the day before 
the assay. Copper rings, up to four per plate, were melted into the dried agar plates and 
used as corrals for different strains within a single plate to allow for direct comparison. 
Ethanol plates were treated with an exogenous dose of 300 mM ethanol. First day adult 
worms to be assayed were acclimated off of food for 30 minutes on dried plates 
immediately prior to ethanol exposure. Animals were analyzed visually at time-points 
during ethanol exposure: 10, 20, 30, 40, and 50 minutes. Speed, body bends, forward 
progression, and body movements were observed and described. 
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Creating recombinants for genetic mapping 
We performed genetic mapping using a recombination strategy between the 
mutant strain (in an N2 background) and a genetically polymorphic mapping strain, 
CB4856. In order to perform genetic mapping, recombinant mutant animals were 
created. The mutant bet11, a slow developer of AFT was identified through the 
mutagenesis screen and was used to create recombinants in order to identify the 
location of the mutation responsible for the worms’ suppressed ethanol response. 
Recombinants were created in a background of N2 and CB4856 since both strains are 
fully sequenced and contain natural variations between them (Figure 2A). They contain 
approximately one single nucleotide polymorphism (SNP) every 800 bp on average. 
The bet11 mutant was generated in the npr-1(ky13) strain, which is in the N2 genetic 
background. The npr-1(ky13) mutant animals are fast developers of AFT, whereas the 
bet11 mutation causes them to become slow developers of AFT. The CB4856 strain 
has a low-functioning isoform at npr-1 and is a fast developer of AFT. Normally, the 
progeny of C. elegans hermaphrodite self-fertilization are almost all hermaphrodites, but 
we can identify successfully mated animals because they will generate approximately a 
50% male progeny and the progeny will be heterozygous animals. npr-1(ky13) animals 
were mated with CB4856 males and we picked heterozygous F1 animals and allowed 
them to self-fertilize to produce the F2 generation (Figure 2B). In the F2 generation, the 
animals will have a random assortment of genotypes. F2 animals were then screened 
for the mutant bet11-like phenotype, which is a slow development of AFT. Animals that 
were slow developers of AFT were individually picked and allowed to self-fertilize to 
generate populations. These populations were retested to make certain that the slow 
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development of AFT bred true. Eighty-four recombinants were picked in order to 
determine the location of the mutation. 
DNA isolation and genetic mapping using SNP markers 
DNA from bet11 recombinants was isolated for DNA by washing worms off highly 
populated, healthy plates using 1.7 mL ddH2O and transferring into 1.5 mL Eppendorf 
tubes. Isolated worms were centrifuged for 1 minute, the supernatant was discarded 
and the pellet was washed and resuspended with ddH2O and centrifuged again for 1 
minute. The supernatant was discarded leaving 0.1 mL of worm plus water mixture. 
Tubes were frozen quickly at -80°C to burst open the isolated worms. Frozen worms 
were then further lysed using 35 uL lysis buffer (200 mM KCl, 40.1 mM Tris, 21.4 mM 
MgCl2, 0.164 mM Gelatin, 64.7 mM NP-40, 15.5 mM Tween-20) and 0.42 uL proteinase 
K (0.37 mM) solution per sample. Lysis was performed in a 60°C water bath for 90 
minutes and then at 95°C in a heat block for 25 minutes to inactivate the proteinase K. 
The resulting DNA-containing solution was used in genetic mapping. 
 We began by looking at polymorphisms at three broadly spaced points (markers) 
on each of the six chromosomes (18-point mapping) and identifying the genotype in 
each DNA sample at each specific marker. Identification of N2 or CB4856 DNA was 
determined using snip-SNP or sequencing SNP (Wicks, Yeh et al. 2001). Snip-SNP 
markers are SNPs that interrupt a restriction site, causing one genotype to have an 
endonuclease restriction site that the other genotype lacks. A fragment of DNA that 
contained the SNP marker was amplified using PCR and digested using the appropriate 
restriction enzymes to distinguish between the genotypes of DNA from the recombinant 
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line. In the case that the SNP does not lie within a restriction site, the genotype of the 
SNP was determined using Sanger sequencing of a fragment spanning the SNP that 
had been amplified using PCR. When all 18-points of genetic mapping were genotyped, 
an area of high incidence of N2, which should segregate with the bet11 mutation, 
identified the mutation location. Finer genetic mapping was utilized to pinpoint the 
mutation using additional SNPs. 
RNAi induction and ethanol assay 
RNAi by feeding is accomplished by feeding worms bacteria that produces a 
dsRNA, that induces an RNAi response by degrading a specific mRNA. Specific clones 
of the Ahringer library were used to knockdown specific genes that lay within our 
mapped interval for the bet11 mutation. npr-1(ky13) animals were used with the 
expectation that if the gene affected by RNAi is the same gene affected by bet11 then 
we would expect to see a reproduction of the bet11 mutant phenotype, that is, a slow 
development of AFT. Samples from frozen RNAi cultures were inoculated in LB and 50 
µg/µL ampicillin, shaken at 37°C overnight, and stored at 4°C for up to a week. RNAi 
agar plates were prepared using a NGM agar media with IPTG (to induce production of 
the double stranded RNA) and ampicillin (for selection to maintain the plasmid) added to 
it. RNAi liquid cultures (100 µL) were spread onto agar plates and allowed to grow 
overnight before use. Four to five late L3 or young L4 animals were moved onto a 
seeded RNAi plate, and allowed to continue to develop into adults. Animals were moved 
36-40 hours later to freshly seeded RNAi plates and allowed to lay eggs for 2 hours. 
Adults were removed and the F1 progeny that had grown in the presence of the RNAi-
containing bacteria were tested for ethanol sensitivity and AFT to 400 mM ethanol. 
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Transformation by microinjection to rescue phenotype 
Yeast artificial chromosomes (YACs) and cosmids were microinjected directly 
into the distal gonad of the C. elegans to transform progeny of the injected animals with 
random extrachromosomal DNA arrays containing the injected DNA (Evans 2006). 
Cosmid DNA was purified using an alkaline lysis kit. The bet11;npr-1(ky13) animals 
were injected using a pulled borosilicate glass capillaries with a fine internal glass 
filament. Animals were submerged in halocarbon oil and then adhered and immobilized 
on 2% agarose pads. Injections were done using a Zeiss Axiovert inverted DIC 
microscope and a micromanipulator was used for fine positioning of the needle. The 
flow of the DNA was regulated by a pressurized injection system. Once the needle was 
inserted into the distal gonad of the worm, the DNA solution (YAC: 130 ng/µL and 
H20::gfp: 10 ng/µL; Cosmid: 30 – 45 ng/µL and H20::gfp: 10 ng/µL) was injected so that 
the solution flows freely in both direction and the gonad begins to swell up. Animals 
were recovered from immobilization using M9 solution and injected P0 animals were 
transferred to seeded NGM plates. F1 animals were checked for transformation (H20 – 
pan-neuronal GFP marker); if the marker was present, animals were individually picked 
as an individual transformed line and F2 animals carrying the extrachromosomal arrays 
were tested on 400 mM ethanol for rescue. 
Whole genome sequencing 
First day starved adult worms were washed from multiple plates with M9 into a 
15 mL plastic conical tube in order to obtain at least 500 µL of worms. Worms were 
pelleted and washed with M9. This was repeated two more times and then flash-frozen 
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in the -80°C freezer. DNA was isolated using Puregene Core Kit A for isolation from 
tissue (Qiagen). Isolated DNA samples were sequenced using next generation whole 
genome sequencing at the Center for the Study of Biological Complexity (VCU) using a 
single channel.  
Results:  
bet11;npr-1(ky13), a slow developer of AFT 
npr-1(ky13) animals are fast developers of AFT and were mutagenized in order 
to create and identify animals with disrupted development of tolerance to ethanol (slow 
developers of AFT).  The F2 progeny of the mutagenized animals were screened and 
individually isolated by a chemotaxis assay in the presence of ethanol. The progeny of 
these slow developers of AFT were analyzed several times by visual ethanol assays 
and only animals that continued to exhibit reduced AFT to ethanol were kept and 
individually maintained. Animals that failed to reproduce the slow development of 
tolerance phenotype could have been previously injured or have been inadvertently 
picked due to environmental factors. Out of the 2600 mutant genomes screened, 16 
animals that had increased ethanol-sensitivity, relative to npr-1(ky13), were isolated. 
From this screen, bet11;npr-1(ky13) was isolated and further investigated as a mutant 
defective in the development of AFT (Figure 3). 
bet11 genetically mapped to chromosome I  
To locate the gene that mediates ethanol sensitivity in bet11;npr-1(ky13), 
recombinants were created by crossing the mutant to a mapping strain, CB4856. Single 
nucleotide polymorphisms between npr-1(ky13) (N2 genetic background) and CB4856 
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(low-function npr-1 allele) were utilized as markers to map the bet11 ethanol-sensitivity 
mutation. Initially mapping at three broad points within each of the six chromosomes 
(18-point mapping), the position of the bet11 mutation was narrowed to the left arm of 
chromosome I. After finer SNP mapping, the mutation was narrowed further to an 
interval between -12.0 and -7.31 C. elegans map units (Figure 4). This interval was 
approximately 900 kb and contained roughly 150 genes.  
F23C8 rescued bet11 through transformation rescue  
Different yeast artificial chromosomes (YAC) or cosmids containing wild-type 
genomic DNA from within the narrowed bet11 mapping region were used to rescue the 
mutant’s slow development of AFT phenotype to a fast development of AFT. I was able 
to inject wild-type copies of these genomic DNA constructs into bet11;npr-1(ky13) and 
produce extrachromosomal DNA arrays (Figure 5). Transformed bet11 animals were 
assessed to determine if the transformed DNA rescued the phenotypic fast 
development of AFT. Within the interval, the following YACs and cosmids were 
successfully transformed into bet11;npr-1(ky13): Y39G10, C55C2, F12B6, F23C8, 
T16H5. All transformants were subjected to a 400 mM visual ethanol assay. 
Y39G10AR, C55C2, F12B6, and T16H5 failed to rescue bet11’s slow development of 
AFT. F23C8 was able to partially rescue bet11 and was further investigated. Genes 
within the F23C8 cosmid were filtered and narrowed by their position within coding 
regions. Two mutants, F23C8.6(ok3325), which contains a 702 base pair deletion and 
F23C8.7(tm3994), which has a 224 base pair deletion were tested on 400 mM ethanol 
at 10, 20, 30, 40, and 50 minutes to see if either mutation could phenocopy the bet11 
mutation phenotype. The deletion mutants were visually compared to wild-type N2, npr-
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1(ky13), and bet11;npr-1(ky13) to determine their ethanol response. F23C8.6(ok3325) 
and F23C8.6(ok3325);npr-1(ky13) showed phenotypes on ethanol similar to N2 and  
npr-1(ky13) respectively, whereas F23C8.7(tm3994) showed a slower development of 
AFT phenotype to ethanol relative to N2, but did not phenocopy bet11’s ethanol-
sensitivity phenotype. The tm3994 animals had a unique response to ethanol, where 
there was little forward movement, but an increase in head and tail movement. The 
strain F23C8,7(tm3994) has yet to be tested in an npr-1(ky13) background. Due to 
F23C8.7(tm3994) increased ethanol sensitivity, F23C8.7 is a possible gene candidate 
for mutant bet11. Additional studies will need to be conducted to verify if F23C8.7 is the 
gene mutated by bet11. 
Two gene targets identified through whole genome sequencing 
We performed whole genome sequencing on bet11;npr-1(ky13) and bet14;npr-
1(ky13) simultaneously. The bet14;npr-1(ky13) mutant was isolated as a slow developer 
of AFT from the same mutagenesis screen as bet11;npr-1(ky13), but it has been 
mapped to a separate location and chromosome. Both mutants were generated in the 
same npr-1(ky13) strain, which allowed for common variations found in both mutants to 
be attributed to the parent strain npr-1(ky13). By eliminating these common variants, we 
are left with variants that are unique to bet11 and bet14. The analysis of bet11 found 
that there were two coding region mutations within two separate genes in the mapped 
area of interest (Figure 6). A putative histone methyltransferase found homologous to 
other C. elegans and human genes (Y39G10AR.18) was located at CI:-8.83 and 
contained a proline to serine missense mutation. The second mutation was located at 
CI:-12.32 and contained a proline to leucine missense mutation within the gene 
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Y20F4.4. The Y20F4.4 gene is uncharacterized in the worm, but was found to be 
homologous to the human gene SRRM2, a serine/arginine repetitive matrix protein 2. 
The SRRM2 protein is known to show high alternative RNA splicing in neuronal sources 
and blood of Parkinson’s disease patients (Shehadeh, Yu et al. 2010). The gene 
mutated by bet14, which has been mapped to chromosome II has not been further 
identified.  
Discussion  
An ethanol sensitive mutant bet11;npr-1(ky13) was isolated following EMS 
mutagenesis of a fast developer of AFT, npr-1(ky13). The gene that mediates the slow 
development of AFT and ethanol sensitivity in bet11 was localized by genetic 18-point 
mapping using SNPs. Mapped to the left arm of chromosome I, bet11 was further 
investigated by finer genetic mapping within this area of interest. The interval of interest 
was narrowed down between map units -12.0 and -7.31 as the potential location of 
bet11. This allowed for the utilization of transformation rescue. Transformation of 
cosmid F23C8 by microinjection partially rescued the bet11 phenotype from a slow 
developer of AFT to a faster developer of AFT. Deletion alleles within the F23C8 
cosmid, F23C8.6(ok3325) and F23C8.7(tm3994) were analyzed by testing them on a 
visual ethanol assay. If the bet11 mutation lies within F23C8.6 or F23C8.7, the deletion 
allele strains in a npr-1(ky13) background would phenocopy the bet11 slow 
development of AFT.  Both F23C8.6(ok3325) and F23C8.6(ok3325);npr-1(ky13) failed 
to phenocopy bet11’s slow development of AFT phenotype, nor suppress the npr-
1(ky13) fast development of AFT, suggesting that bet11 does not lie within the F23C8.6 
gene. F23C8.7(tm3994) was sensitive to ethanol, but F23C8.7(tm3994);npr-1(ky13) has 
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not been tested for its ethanol response. If tm3994 is able to suppress npr-1(ky13), the 
fast developer of AFT phenotype, then F23C8.7 is a potential gene candidate for bet11. 
This coincides with the bet11 whole genome sequencing results, where no mutations 
were found within the open reading frame of F23C8 and there was a decrease in the 
ethanol sensitivity response of F23C8.6(ok3325) deletion allele. It is however possible 
that a F23C8.7 mutation was not detected in the whole genome sequencing results if 
the mutation is located within the promoter region or contained a deletion that was not 
detected through the sequencing analysis program. In contrast, another possibility since 
F23C8 was able to partially rescue bet11, that there is an over-expression of a gene 
with a role in AFT other than the gene affected by the bet11 mutation. This can be 
further investigated and clarified by identifying the F23C8.7(tm3994);npr-1(ky13) 
ethanol sensitivity. Sequencing identified two functional mutations in Y20F4.4 and 
Y39G10AR.18 were found within the mapped chromosome I region. These two genes 
provide us with a promising lead to a potential regulator of AFT to ethanol, where 
Y39G10AR.18 is a more likely candidate. This is due to its location closer to the center 
of our genetically mapped area of interest.  
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Figure 2. Identifying and genetically mapping bet11 recombinants 
(A) Basis of genetic mapping. N2 and CB4856 were crossed in order to create bet11 
recombinant animals in order to locate the bet11 mutation. N2, a slow developer of AFT, 
has a null mutation at npr-1 and becomes a fast developer of AFT. When npr-1(0) is 
mutatgenized creating a mutation at bet11, it changes this N2 from a fast developer of 
AFT to a slow developer of AFT. CB4856 has a low-functioning allele at npr-1 and is 
wild-type wherever bet11 is located. (B) Creating bet11 recombinants for genetic 
mapping. The mutant bet11;npr-1(0)(N2) was crossed to CB4856;npr-1(lf) and in the F2 
generation there were a random assortment of genotypes. By isolating only animals that 
had a similar phenotype as bet11, after creating a map, there will be one identifiable 
location where bet11 mutation lies.  
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Figure 3. bet11;npr-1(ky13) ethanol sensitivity 
Mutant bet11;npr-1(ky13) is a slower developer of AFT relative to npr-1(ky13). N2 has 
similar ethanol sensitivity to bet11;npr-1(ky13) and npr-1(ky13) recovers and develops 
tolerance much faster than N2 by 30 minutes. 
One-way ANOVA  
p-value<0.05 
post-hoc – Bonferroni test 
*, #, + relative to 10 minute time point within strain 
** relative to N2 
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Figure 4. bet11 genetic mapping 
Using SNP markers for genetic mapping, the bet11 mutation was mapped to the left 
arm of chromosome I between map units -12.00 and -7.31. bet11 mapped to the CI:-
8.00 SNP 100%.    
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Figure 5. Transformation rescue interval 
bet11;npr-1(ky13) animals were microinjected with wild type extrachromosomal DNA of 
various overlapping YACs and cosmids within the area of interest. Upon successful 
transformation, animals were analyzed on 400 mM ethanol assay to determine if the 
transformant was able to rescue bet11. Y39G10AR, F12B6, F23C8, T16H5, and C55C2 
were transformed into bet11;npr-1(ky13) and F23C8 was the only transformed line to be 
successfully rescued.  
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Figure 6. bet11;npr-1(ky13) whole genome sequencing  
Whole genome sequencing was performed on an Illumina platform. bet11;npr-1(ky13) 
and bet14;npr-1(ky13) were sequenced simultaneously and mutations that were shared 
between the two were assumed to be the result of the npr-1(ky13) background and 
mutations were disregarded. Mutations within the genetically mapped area on 
chromosome I showed two functional polymorphisms, one in Y39G10AR.18 and the 
other in Y20F4.4. 
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Chapter 3: Additional contributors to ethanol sensitivity and AFT 
 
Alcoholism is mediated by multiple targets 
Alcoholism is a complex disorder and it has become apparent in human and 
animal genetic studies that there is not a single gene that mediates alcohol-related 
diseases and alcoholism. The large scale Collaborative Studies on Genetics of 
Alcoholism (COGA) human genetics study has worked to identify genes that cause 
vulnerability to alcohol dependence. Advancements by COGA have been useful in 
identifying and locating some genes associated with alcohol-related problems 
(Gunzerath, Hewitt et al. 2011). Whole genome linkage studies have identified multiple 
chromosomal regions that have been linked to alcohol dependence. While there are 
also several genes that have been consistently shown to play a role in alcohol 
dependence such as the alcohol metabolizing enzymes ALDH2 and ADH1B, and the 
neurotransmitter receptor GABRA2, other genes that have been shown to be involved in 
neural transmission have not been as consistently implicated across studies (Kimura 
and Higuchi 2011). This is due to the genetic heterogeneity of the human populations 
within and between different studies. Alcohol has been linked to a number of 
interactions with neurotransmitters and changes in serotonin, noradrenaline, and 
dopamine (Nutt 1999). Continuing identification of variants to refine genetic studies by 
classifying homogeneous phenotypes will allow better identification of alcohol-related 
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disease associated genes and a better understanding of the interactions between 
multiple targets. 
Previously mapped slow developers of AFT in C. elegans 
In our laboratory, many mutations that cause slow development of AFT have 
been isolated and mapped. These mutants were isolated from the same mutagenesis 
as bet11 and mutant recombinants were created similarly to how the bet11 
recombinants were made. Mutant animals in a N2;npr-1(0) background were crossed 
with CB4856;npr-1(lf) and in the F1 generation all animals were heterozygous for 
N2;npr-1(0) and CB4856;npr-1(lf). In the F2 generation, animals that had a slow 
development of AFT were picked. To be a slow developer of AFT, the F2 animals must 
be homozygous for the mutation that causes a slow development of AFT. When enough 
animals have been isolated and genotyped at different marker locations, there should 
be one location that that contains a high incidence of the mutation’s parent genome 
genotype (N2). This location of the mutation from genetic mapping is hypothesized to 
only map to one area of interest. However, after mapping multiple, non-allelic mutants, 
the laboratory noted that in every case, ¾ of the recombinants would map the mutation 
to one location and the remaining ¼ of the recombinants would map it to an unknown 
location (Figure 7A). Animals within this ¼ were tested for complementation with the 
parent mutant and complemented, suggesting that they are not homozygous for the 
induced mutation and therefore are not defective in AFT due to the induced mutation. 
These results for genetic mapping were surprising and not very well understood, but the 
¾ of recombinants that did generate mapping data to a specific location and allowed the 
cloning of two non-allelic mutants (Bettinger et al. unpublished). This suggested that the 
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slow development of these ¼ of recombinants that mapped to another location was 
slow due to a reason other than the mutation and may have originated from differences 
in the genetic background.  
Synthetic hypersensitive animals were discovered 
To better understand what contributes to this unknown slow development of 
tolerance, the background of the cross was investigated (Figure 7B). N2;npr-1(0) and 
CB4856;npr-1(lf) are both fast developers of tolerance and when maintained on their 
own will always be fast developers of tolerance. A cross was performed, and in the F1 
generation, all animals were heterozygous and in the F2 generation, a majority (15/16) of 
the animals were fast developers of AFT, but a small subset (1/16) were slow developers 
of AFT. This was intriguing because two parents that are fast developers of AFT were 
able to generate progeny that were slow developers of AFT. These results correlated 
with the mutant mapping results, where ¼ of the F2 progeny had similar tolerance as the 
mutant and ¼ of those animals genetically mapped to another location, thus generating 
1/16 of the entire F2 progeny that develops tolerance slower, but its not allelic to the 
parent mutant (Figure 7A). This allowed us to discover that there is a unique 
combination of N2 and CB4856 alleles that on their own are fast developers of AFT, but 
together produce a slow development of AFT phenotype (Figure 8). In order to generate 
this new phenotype, which we have named the synthetic hypersensitive phenotype, two 
unlinked homozygous N2 and CB4856 alleles have to come together.  
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bet11 produces its own unique genetic mapping pattern 
As described in Chapter 2, bet11;npr-1(ky13), a slow developer of AFT was 
isolated from the genetic background of a fast developer of AFT, npr-1(ky13). npr-
1(ky13) contains a null mutation on chromosome X in a N2 background and was 
mutagenized in an EMS screen in order to identify other regulators of AFT besides npr-
1. To identify the bet11 mutation, I mapped it by crossing with CB4856;npr-1(lf). We 
made an interesting observation when mapping bet11, where instead of the previously 
observed ¾ mapping to one location and the remaining ¼ map to another unknown 
location, bet11 mapped 100% to one particular map location (map unit: -8.00) on 
chromosome I (Figure 4, Figure 7C). The absence of the remaining ¼ was notable and 
prompted the following experiments to explain that outcome.  
Specific Aim 2: Identify contributing regulators of acute functional tolerance associated 
with bet11 though synthetic hypersensitive animals. 
Rationale: After isolation of bet11;npr-1(ky13), an ethanol sensitive and slow developer 
of AFT, we propose that the gene affected by the bet11 mutation may be one of the 
contributors of the synthetic hypersensitive phenotype. This was suggested by the 
observation that bet11 mapped completely to one area of the genome, unlike previously 
mapped ethanol responsive animals (Figure 4). After crossing two fast developers of 
AFT, CB4856;npr-1(ky13) and N2;npr-1(ky13) in a mutagenesis-free analysis, the F2 
generation contained a small portion of animals in the F2 generation that are slow 
developers of AFT. We believe that there is a CB4856 allele for one gene and an N2 
allele for a different gene, that when each are homozygous together in the same strain, 
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contribute to an ethanol sensitive phenotype. We believe that the gene mutated by 
bet11 described in Chapter 2 identifies the N2 allele described here, and here we utilize 
a similar approach to identify the CB4856 synthetic hypersensitive allele through 
forward genetics and genetic mapping.  
Materials and Methods  
Strains 
Nematodes were maintained on nematode growth medium (NGM) agar plates 
seeded with OP50, E. coli food, and kept at 20°C. The strains that were used in this 
study were: N2, CB4856, CB4856 Recombinant inbred line (RIL) 29, CB4856 RIL30, 
CB4856 RIL34, CB4856 RIL35, CB4856 RIL36, CB4856 RIL37, npr-1(ky13), bet11;npr-
1(ky13). Strains were provided by J. Bettinger (Virginia Commonwealth University, 
Richmond, VA), J. Kammenga (Univ. of Groningen, The Netherlands) and the C. 
elegans Genetics Center (University of Minnesota, Minneapolis, MN).   
RIL;npr-1(ky13) double mutant 
CB4856 RILs were crossed with npr-1(ky13) males and plated individually. 
Successfully mated animals were identified, and their progeny were isolated and 
maintained, and specific RIL and npr-1(ky13) SNP markers were used in PCR to verify 
the generation of the double mutant.  
Ethanol sensitivity and acute functional tolerance assay 
Animals were tested for ethanol response using the same procedures as 
described in Chapter 2. 
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Computer locomotor assay 
Assay plates were dried for 90 minutes and L4 animals to assay were picked the 
day before the assay. On the day of the assay, copper rings were melted into the plate 
in order to corral different strains of animals within one plate. Cold ethanol (100%) was 
placed on plates based on their weight to the appropriate final concentration two hours 
prior to the beginning of the assay and adult animals were acclimated off food for 30 
minutes prior to the start of the assay. Each ethanol plate had a parallel control (0 mM 
ethanol) plate. Movies were made on an Olympus SZX-7 stereo microscope (0.8x 
magnification and 0.5x objective) using a Retiga 4000R camera (QImaging) and 
ImagePro Plus (6.2) (MediaCybernetics) software. Ten animals were picked per ring 
and two-minute recordings (1 frame per second) were captured at 10, 30, and 50 
minutes during continuous ethanol exposure. The speed of each worm was tracked 
using ImagePro plus software and an average speed for each group of ten animals was 
calculated.  
Genetic mapping using SNP markers 
DNA from CB4856 RILs was isolated as described in Chapter 2. Identification of 
specific alleles was determined using snip-SNP markers within chromosome III; SNPs 
were amplified using PCR and digested using appropriate restriction enzymes in order 
to differentiate N2 or CB4856 genotype at particular marker.  
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Results  
Homozygous bet11 is not distinguishable from synthetic hypersensitive animals 
The observation of the synthetic hypersensitivity produced by N2;npr-1(ky13) and 
CB4856;npr-1(ky13), in combination with the absence of synthetic hypersensitive 
animals in the mapping of bet11, led us to predict that the fact that we appeared to not 
be isolating any synthetic hypersensitive animals in the bet11 mapping could be 
explained by bet11 having a distinguishable phenotype. We hypothesized that if bet11 
had a unique or special ethanol sensitive phenotype, that when isolating recombinants, I 
was able to pick out only true bet11 recombinants. This would result in a 100% accurate 
map of the mutation to one locus and select against the synthetic hypersensitive 
animals. I reanalyzed bet11, its recombinants, and the known synthetic hypersensitives 
identified by mapping other mutants and did not find any noticeable phenotypic 
difference between all of the animals. This hypothesis therefore was abandoned, since 
it was not plausible that I could have randomly picked only bet11 mutant recombinants.   
The bet11 mutation is allelic to the N2 synthetic hypersensitive allele 
Since bet11 was not distinguishable from the synthetic hypersensitives, the most 
logical explanation would be that the bet11 mutation affects the same gene as the N2 
allele of the synthetic hypersensitive double mutant. I tested this by performing a 
complementation test between bet11 and some of the known synthetic hypersensitives 
generated from the cross of CB4856 and N2 (npr-1(ky13)). All synthetic hypersensitive 
animals failed to complement bet11, suggesting that bet11 and the N2 allele that 
contributes to synthetic hypersensitivity are located within the same gene (Figure 9). I 
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further analyzed the known synthetic hypersensitive animals generated during mapping 
of other AFT mutants by running PCR at the SNP (CI: -8.00) that is tightly linked to the 
bet11 mutation (Figure 10). If bet11 mapped to a different chromosome than the 
synthetic hypersensitive allele, there would a 50:50 ratio of N2 background or CB4856 
background. I found that these animals mapped highly as N2 (95%) to the CI: -8.00 
SNP. This suggested that the N2 synthetic hypersensitive allele maps to the same 
genetic location as the bet11 mutation. These results strongly support the hypothesis 
that the bet11 mutation affects the same gene as one of the genes involved in synthetic 
hypersensitivity. Therefore, by identifying the mutation that underlies bet11, we will 
simultaneously identify the N2 allele that contributes to synthetic hypersensitivity. 
CB4856 synthetic hypersensitive allele is located on chromosome III 
While I was able to localize the N2 synthetic hypersensitive allele through bet11, 
to identify the CB4856 contribution our laboratory was fortunate to be able to obtain a 
subset of CB4856 recombinant inbred lines (RILs) that contain various segments of 
CB4856 DNA in a N2 background (Figure 11) (Doroszuk, Snoek et al. 2009) The set of 
90 lines span all chromosomes and cover 95.91% of the C. elegans genome based on 
chromosomal base pair coverage. The surviving strains (88 out of 90) received were 
assayed for ethanol sensitivity at 200 mM and 400 mM ethanol (Blackwell, Bettinger et 
al., unpublished). This enabled us to study the majority of the genome and test certain 
areas within the genome for genetic variations that affect ethanol sensitivity and 
tolerance. There was a single distinct group of RILs that portrayed sensitivity to ethanol, 
where all the other lines had similar or resistant phenotypes relative to N2. This 
sensitive subset had different fragments and segment lengths of CB4856 DNA, but all 
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were derived from chromosome III. RIL29, RIL35, and RIL36 were within this subset 
and each have different levels of ethanol sensitivity and AFT compared to N2 and 
CB4856 (Figure 12, Figure 13, Figure 14). To verify if these RILs within chromosome III 
played a role in synthetic hypersensitivity, I put npr-1(ky13), a fast developer of AFT into 
the background of the ethanol sensitive RILs. RIL29;npr-1(ky13) and RIL35;npr-1(ky13) 
were visually assayed and video tracked for locomotion to test for ethanol sensitivity at 
400mM (Figure 12, Figure 13). npr-1(ky13)’s fast development of AFT was suppressed 
by both RIL29 and RIL35. Conversely, RIL36, which has a CB4856 segment that largely 
overlaps RIL35, was also assayed on ethanol, but when placed in an npr-1(ky13) 
background, RIL36 did not suppress the npr-1(ky13) phenotype (Figure 14). The 
phenotypes of these strains provided good evidence that the CB4856 allele that 
contributes to synthetic hypersensitivity lies within the CB4856 segment of chromosome 
III of the RIL29 and RIL35 sensitive lines. 
To identify the mutation that causes synthetic hypersensitivity in CB4856, I 
performed genetic mapping using SNP markers. Ethanol sensitive and resistant RILs 
were mapped and areas that contained similarities between strains that were able to 
suppress npr-1(ky13)’s fast development of tolerance were identified. Strains that were 
not able to suppress the fast tolerance were eliminated as the potential location of the 
CB4856 synthetic hypersensitive allele. Since RIL29 and RIL35 suppressed npr-
1(ky13)‘s tolerance phenotype, the two strains can be used in determining where the 
allele lies compared with other strains that were not able to suppress the fast 
development of tolerance phenotype. This elimination method allowed for further 
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isolation of the CB4856 allele, which has been narrowed down on chromosome III 
between -16.02 and -12 (Figure 15).  
Discussion  
Initially, we thought that bet11 had a unique and distinguishable phenotype that 
allowed for easy isolation of recombinants and hence produced a 100% mapping data 
to one locus. After further comparison with synthetic hypersensitive animals and other 
sensitive mutants, I found that there was no obvious visual sensitive phenotypic 
difference. This lead us to what we believe is the easiest explanation, that bet11 
contains a mutation in the same gene that has variation that underlies synthetic 
hypersensitivity and it is the homozygous N2 allele that contributes in combination with 
the homozygous CB4856 allele to produce ethanol sensitivity.  bet11 failed to 
complement the synthetic hypersensitive animals suggesting that the variation lies 
within the same gene. When the synthetic hypersensitive animals were mapped at the 
bet11 locus, they mapped highly to the CI: -8.00 locus. The results favor the idea that 
both the N2 allele and the CB4856 allele are low-functioning alleles that on their own do 
not produce a detectable sensitive phenotype, but in combination produce an additive 
and detectable ethanol sensitive phenotype. By identifying bet11, it will simultaneously 
identify the N2 synthetic hypersensitive gene. RILs constructed by Kammenga’s 
laboratory were utilized to identify the CB4856 allele. The RILs contained various size 
segments of CB4856 DNA within a N2 background. Out of the 88 strains analyzed for 
ethanol sensitivity, there was only one area that showed increased ethanol sensitivity. 
The area was located in a large interval on chromosome III. Further investigation within 
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chromosome III, through genetic mapping of RILs showed that the CB4856 allele lies 
within chromosome III between map units -16.02 and -12.  
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Figure 7. Identifying synthetic hypersensitives 
npr-1(0) and CB4856 animals are always fast developers of AFT relative to N2.  
(A) Previously mapped mutants. Through forward genetic mapping, it was identified 
that when crossing mutagenized animals (in an N2 background) with CB4856, ¼ were 
ethanol sensitive in the F2  generation and approximately ¾ would map to one location 
and approximately ¼ would map to somewhere else in the genome.  (B) Identifying 
synthetic hypersensitives. When npr-1(0) and CB4856 are mated (without 
mutagenesis), in the F2 generation there is mostly animals that are fast developers of 
AFT, but there is a small portion (1/16) of animals that are slow developers of AFT.  
(C) bet11 mapped 100% to one location. When bet11 was genetically mapped, ¼ of 
the animals in the F2 progeny were ethanol sensitive and 100% of these sensitive 
animals identified its mutation to one locus.  
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Figure 8. Two unlinked alleles in combination produce a synthetic hypersensitive 
phenotype 
A unique combination of a low-functioning homozygous N2 allele in one gene and a 
low-functioning homozygous CB4856 allele in a different gene produces synthetic 
hypersensitivity. The homozygous N2 allele (kfg-1(N2))on its own is a fast developer of 
AFT and the homozygous CB4856 allele (kfg-2(N2)) on its own is a fast developer of 
AFT. Two fast developers of AFT animals create a synthetic slow developer of AFT. 
kfg – Kapo’s favorite gene/genes of interest 
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Figure 9. bet11 and synthetic hypersensitive animals failed to complement  
The mutant bet11 and the synthetic hypersensitive animals in the F1 generation 
produced a slow development of AFT phenotype. In this scenario for ease we 
hypothesized that high-function has 100% of function, low-function equaled 50% of 
function, and null has 0% or no function. We identified that the synthetic hypersensitives 
have two unlinked low-functioning alleles in two separate genes. The genes of interest 
are depicted here as kfg (Ka-Po’s favorite gene). The synthetic hypersensitives are 
shown to have a high-functioning (full function – ff) CB4856 allele and a low-function (lf) 
N2 allele in kfg-1. In kfg-2, CB4856 has a low-functioning allele and N2 has a high-
functioning allele. Together the alleles in both genes produce a slow development of 
AFT phenotype. The bet11 allele alone is able to produce the same slow development 
of AFT phenotype, even in the absence of the CB4856 allele, suggesting that it is a 
strong loss-of-function allele. To analyze this, different combinations of alleles with 
varied levels of function were assessed by phenotype. The mutant bet11 crossed with a 
synthetic hypersensitive produced a slow developer of AFT. The combination that 
produces a slow developer of AFT must contain bet11(0) and N2(lf) in the same gene, 
thus mutant bet11 and the synthetic hypersensitives failed to complement. If bet11 and 
the synthetic hypersensitves were different genes it would produce a fast developer of 
AFT F1 animal.  
*Could be ky13 or CB4856 allele 
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bet8 Synthetic Hypersensitives CI: -8.00
4 N2
18 N2
28 N2
49 N2
51 N2
52 N2
55 N2
59 N2
eg626 Synthetic Hypersensitives CI: -8.00
6.6.2 N2
8.1.8 N2
10.6.1 N2
9.1.2 N2
8.7.7 N2
10.5.1 N2
10.7.6 N2
10.7.3 CB
115.2 N2
62.1 N2
29.7 (LRC) N2
53.3 (LRC) N2
73.3 (LRC) N2
95% N2
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Figure 10. Synthetic hypersensitive map at CI: -8.00 SNP 
Genetically mapping the synthetic hypersensitive animals of other ethanol mutants 
showed that the N2-ness mapped 95% to the chromosome I -8.00 locus. This 
suggested that bet11 mapped directly to the synthetic hypersensitive allele and that 
bet11 is a synthetic hypersensitive animal. 
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Figure 11. Recombinant inbred lines 
Ninety recombinant inbred lines were constructed that consist of segments of CB4856 
DNA (shown in red) spanned the genome and lies within a N2 background (shown in 
green). Eighty-eight of the ninety strains were tested for ethanol response and found 
that throughout the entire genome only strains within a portion of chromosome III 
showed ethanol sensitivity relative to N2. All other strains showed similar or resistant 
ethanol responses relative to N2. We specifically analyzed RIL29, RIL35, and RIL36 
within chromosome III that portrayed ethanol sensitivity. 
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Figure 12. RIL29;npr-1(ky13) ethanol response 
RIL29 is an ethanol sensitive strain and contains a small portion of CB4856 DNA within 
a N2 background. It is more sensitive than N2 and does not develop AFT. RIL29;npr-
1(ky13) suppresses the npr-1(ky13) phenotype.  
One-way ANOVA 
p-value<0.05 
post-hoc – Bonferroni test 
+ relative to 10 minute time point within strain 
** relative to N2 
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Figure 13. RIL35;npr-1(ky13) ethanol response 
RIL35 is an ethanol sensitive strain that contains a small portion of CB4856 DNA within 
a N2 background. It is more sensitive than N2 and does not develop AFT. RIL35;npr-
1(ky13) suppresses the npr-1(ky13) phenotype, as npr-1(ky13) is a faster developer of 
AFT relative to the other strains.  
One-way ANOVA  
p-value<0.05 
post-hoc – Bonferroni test 
# relative to 10 minute time point within strain 
** relative to N2 
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Figure 14. RIL36;npr-1(ky13) ethanol response 
RIL36 is a line that directly overlaps the CB4856 portion of RIL 35. It is an ethanol 
sensitive strain and has similar development of AFT as N2. It is slightly more sensitive 
than N2, but RIL36;npr-1(ky13) does not suppress the npr-1(ky13) phenotype. 
One-way ANOVA  
p-value<0.05 
post-hoc – Bonferroni test 
#, % relative to 10 minute time point within strain 
** relative to N2 
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Figure 15. CB4856 synthetic hypersensitive allele genetic map 
The RIL’s were genetically mapped using SNPs markers. Based on their sensitivity to 
ethanol, the CB4856 synthetic hypersensitive allele has been narrowed to an interval on 
chromosome III between -16.02 and -12.00. 
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Chapter 4: Quantifying lipid levels in respect to ethanol sensitivity 
 
The role of lipids in ethanol sensitivity 
Through similar forward genetic screening as described in Chapter 2, we found 
genes involved in a pathway that putatively regulates triacylglcerides (TAG) through the 
lipase, LIPS-7 (Figure 1). ctbp-1, a transcriptional co-repressor negatively regulates lips-
7, which in turn modulates the levels of TAG. TAG and lipids have been shown to play a 
role in mediating the response to ethanol. We know from previous studies that ctbp-
1(eg613) is a slow developer of AFT and lips-7(ok3110) is a fast developer of AFT 
(Bettinger, Leung et al., unpublished). By better understanding the role of 
triacylglycerides and how varied levels of lipids can mediate ethanol sensitivity and 
tolerance, we may be able to identify new mediators and link TAGs to previously 
identified gene mediators.  
Specific Aim 3: Quantifying triacylgylceride levels in varied ethanol responsive animals.  
Rationale: Studies have shown that lipids and TAG levels play a role in response to 
ethanol activation (Treistman and Martin 2009). Lipids levels may modulate the ethanol 
response through BK and other voltage-gated potassium channels. Understanding the 
relationship of different levels of TAG of varied ethanol responsive animals will provide a 
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gateway to understanding the molecular mechanisms of ethanol’s action and a possible 
approach to identifying and characterizing future ethanol sensitive animals. 
Materials and Method  
Strains 
Nematodes were maintained on nematode growth medium (NGM) agar plates 
seeded with OP50, E. coli food, and kept at 20°C. The strains that were used in this 
study were: N2, lips-7(ok3110), ctbp-1(eg613). Strains were provided by J. Bettinger 
(Virginia Commonwealth University, Richmond, VA) and the C. elegans Genetics 
Center (University of Minnesota, Minneapolis, MN). 
Triacylglyceride level quantification 
Triacylglyceride levels were tested on C. elegans samples using a colormetric 
assay, L-Type Triglyceride M by Wako diagnostics (Richmond, VA). Healthy, non-
starved populations of synchronized first-day adult worms were washed four times in 
M9 buffer, then nutated at room temperature with M9 buffer for 30 minutes to allow 
them to purge any bacteria from their guts. Worms were then washed with ddH20, 
pelleted, flash frozen in liquid nitrogen, and stored at -80˚C until further use. Pelleted 
worms were thawed and ground up using a pestle, and the resulting slurry was dried 
under vacuum on low speed at room temperature. Worms were dried until the pellet 
was translucent and powderized. This powder was reconstituted in double ddH20 and 
the triaclyglyceride concentrations of the samples were normalized by protein 
concentration (Bradford Assay). The assay measures the concentration of 
triacylglycerides in the sample by the absorbance of a blue pigment (Figure 16). A two-
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step procedure allows for free glycerol in the sample to not affect the final 
triacylglyceride level. The free glycerol is decomposed by glycerol kinase (GK), glycerol 
phosphate oxidase (GPO), and catalase. The triacylglycerides in the sample are 
hydrolyzed to glycerol and free fatty acids by lipoprotein lipase. Glycerol is then 
converted to glycerol-3-phosphate by GK and then oxidized by GPO to produce 
hydrogen peroxide. Hydrogen peroxide causes a quantitative oxidative condensation of 
N-(3-sulfopropyl )-3-methoxy-5-methylaniline (HHMPS) and 4-aminoantipyrine 
catalyzed by peroxidase (POD). The assay utilizes the enzymatic method of HHMPS to 
produce a blue pigment that correlates to the amount of triacylglyceride in the sample. 
The triacylglyceride concentration can be calculated by dividing the difference in 
absorbance of triacylglycerides in the sample and free glycerol by a known standards 
triacylglyceride level and free glycerol and then multiplying it by the known standard 
concentration (Figure 17). 
Results 
Preliminary data showed that lips-7(ok3110), which is a fast developer of 
tolerance and is resistant to ethanol relative to N2 has a similar level of triacylglycerides 
as N2. ctbp-1(eg613), a slow developer of AFT and sensitive to ethanol compared to N2 
showed a trend towards a lower level of triacylglyceride compared to N2 (Figure 18).  
Discussion 
Triacylglyceride levels have recently emerged as a likely contributor to ethanol 
sensitivity and AFT. Our working model proposes that triacylglycerides work in 
conjunction with other lipids to modulate the lipid membrane composition. By altering 
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the lipid membrane, our hypothesis is that with an increase in triacylglyceride, there is 
an increase in the number of BK channels that are sequestered into thicker parts of the 
membrane. The sequestered BK channels into the lipid microdomains cause a 
decrease in activation by ethanol and resulted in a resistance response to ethanol 
(Bettinger, Leung et al., unpublished). lips-7 has been shown to regulate lipid levels and 
in response alter the neuronal response to ethanol. After quantifying triacylglyceride 
levels, it was found that lips-7(ok3110), a ethanol resistant strain had similar levels as 
wild-type N2. On the other hand, ctbp-1(eg613), a sensitive strain had a trend towards 
lower levels of triacylglycerides relative to N2. These results did not correlate with a 
previous study identifying a 90% increase in triacylglyceride levels in lips-7(C09E8.2) 
and a 16% decrease in TAG levels in ctbp-1(ok498) (Chen, Whetstine et al. 2009). The 
variation could be attributed to the difference in mutants for lips-7 and ctbp-1 that were 
used to identify TAG levels. RNAi inhibition of the lipase gene, lips-7(C09E8.2), 
resulting in a possibly larger and more pronounce disruption compared to lips-7(ok3110) 
could be responsible for the high TAG levels. We predict that lips-7(ok3110) should 
portray a higher level of TAG and ctbp-1(eg613) should have lower levels of TAG 
compared to N2, which is not seen in our results due to possible limitations in the 
readout of the mass spectrometer. Having low absorbance outputs could have skewed 
our results. Another difference is that we quantified TAG levels using a colormetric 
glycerol based assay, where Chen, Whetstine et al. quantified TAG levels using Nile 
Red staining. We propose that these limitations and differences can be resolved by 
measuring the TAG level absorbencies using an apparatus that can measure a larger 
detectable range and by increasing the sample size. After optimization of quantifying 
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TAG levels, comparing the levels of npr-1(ky13) and bet11;npr-1(ky13) will add another 
layer in understanding the effects of ethanol. 
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Figure 16. Triaclyglyceride concentration quantification reaction 
Free glycerol in each sample is decomposed in the first step by GK, GPO, and catalase. 
The triacylglycerides in the sample are hydrolyzed to glycerol and free fatty acids by 
lipoprotein lipase (LPL). Glycerol is then converted to glycerol-3-phosphate by GK and 
then oxidized by GPO to produce hydrogen peroxide. Hydrogen peroxide causes a 
quantitative oxidative condensation of HHMPS and 4-aminoantipyrine catalyzed by 
POD. HHMPS is utilized to produces a blue pigment that correlates to the amount of 
triacylglyceride in the sample.  
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Figure 17. Triaclyglyceride concentration calculation 
Glycerol in the reaction is converted to a blue pigment that correlates to the amount of 
triacylglyceride in the sample. The concentration of TAG is calculated by the difference 
in absorbencies of the sample and of the known standard and then multiplied by the 
known standard concentration.   
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Figure 18. Triacylglyceride levels in ethanol mediated animals 
lips-7(ok3110), a fast developer of tolerance and resistant to ethanol relative to N2 has 
a similar level of triacylglycerides as N2 triacylglyceride levels. ctbp-1(eg613), a slow 
developer of AFT and sensitive to ethanol relative to N2 trends towards a slightly lower 
level of triacylglyceride compared to N2 levels. There was no significance difference in 
TAG levels between any of the strains. 
One-way ANOVA 
p-value<0.05 
post-hoc – Bonferroni test 
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Chapter 5: Conclusions and Future Studies 
 
Alcohol abuse and alcohol dependence are serious disorders and little is known 
on the molecular mechanism of how ethanol plays a role in the development of these 
disorders. While there are few and ineffective treatments available, much effort is put 
forth in hopes to better understand the role of alcohol to effectively treat and prevent 
these diseases. Using a forward genetic approach, npr-1(ky13), a fast developer of 
tolerance underwent EMS mutagenesis and mutant bet11;npr-1(ky13) was isolated. The 
mutant bet11 is a slow developer of AFT and has been narrowed down to a small 
interval on chromosome I through genetic mapping. Whole genome sequencing 
identified Y20F4.4 and Y39G10AR.18 as the potential candidates for the gene affected 
by the bet11 mutation. Further interrogation of these genes through transformation 
rescue, RNAi, and GFP promoter localization will uncover an important component to 
the multi-facetted molecular mechanism of alcohol and the development of alcohol 
abuse.  
bet11 was initially isolated as a mutation that interrupts a gene that is involved in 
the development of AFT. In the process of identifying bet11, an interesting mapping 
result led us to further investigate the genetic background of the strain used to map 
bet11 and found two unlinked alleles that confer synthetic hypersensitivity. Identifying 
bet11 simultaneously provides a gateway to identify the npr-1(N2) allele of synthetic 
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hypersensitivity. The contributing synthetic hypersensitive, CB4856 allele has been 
mapped to an interval on chromosome III. Identifying the paired synthetic hypersensitive 
alleles and genes that interact in the development of AFT will give new genetic insight 
on the basis of ethanol response and sensitivity. The wild-type N2 allele will further be 
identified through bet11 and the natural variant allele in CB4856 will be further be 
studied by constructing finer genetic mapping within chromosome III. The RIL’s were 
used as a tool to narrow down an interval and identify the gene that the synthetic 
hypersensitive CB4856 allele disrupts. Once the CB4856 allele has been narrowed to a 
smaller interval, transformation rescue and RNAi experiments can be utilized to verify 
the synthetic hypersensitive allele.  
While our laboratory’s main focus is identifying protein mediated ethanol 
response, there has been an increase in interest in understanding how lipid membrane 
environment may play a role in modulating and interacting with these protein ethanol 
targets. Previous studies have shown that triacylglyceride levels and lipid membrane 
thickness may play a role in ethanol sensitivity and tolerance. Quantifying 
triacylglyceride concentrations of ethanol sensitive and resistant mutants showed that 
lips-7(ok3310), a resistant animal has similar lipid concentrations as N2, where ctbp-
1(eg613), an ethanol-sensitive mutant trended towards a lower level of triacylglycerides. 
Future studies to increase the sample size and to optimize the measurement of 
triacylglyceride levels due to low absorbance reads will more accurately quantify the 
differences in lipid levels. Also, identifying triacylglyceride levels of npr-1(ky13) and 
bet11;npr-1(ky13) will continue to advance the possible analysis and screens for 
ethanol sensitivity and tolerance through triacylglyceride level measurements. 
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Alcohol abuse and dependence are serious and common disorders that reflect 
the severe addictive properties and easy access of the drug. With the detrimental 
effects associated with alcoholism along with the rising cost of health care, it is 
imperative to understand the underlying effects of alcohol. The difficulty arises due to 
the fact that ethanol is a simple and highly diffusible molecule, thus making it difficult to 
isolate and identify specific targets and interactions. This has hindered the development 
of effective treatments. Advancements in the area of alcohol research will help promote 
the understanding of how ethanol interacts pharmacodynamically and 
pharmacokinetically. The identification of these ethanol mediators will provide greater 
insight on ethanol’s mechanism of action and help promote the development of effective 
alcohol-related disease treatments.  
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